Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Apr 6:10:13.
doi: 10.1186/1471-2482-10-13.

A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery

Kushagra Verma  1 , Thomas J Errico, Kenneth M Vaz, Baron S Lonner
Affiliations
Randomized Controlled Trial

A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery

Kushagra Verma et al. BMC Surg. .

Abstract

Background: Multilevel spinal fusion surgery has typically been associated with significant blood loss. To limit both the need for transfusions and co-morbidities associated with blood loss, the use of anti-fibrinolytic agents has been proposed. While there is some literature comparing the effectiveness of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) in cardiac procedures, there is currently no literature directly comparing TXA to EACA in orthopedic surgery.

Methods/design: Here we propose a prospective, randomized, double-blinded control study evaluating the effects of TXA, EACA, and placebo for treatment of adolescent idiopathic scoliosis (AIS), neuromuscular scoliosis (NMS), and adult deformity (AD) via corrective spinal surgery. Efficacy will be determined by intraoperative and postoperative blood loss. Other clinical outcomes that will be compared include transfusion rates, preoperative and postoperative hemodynamic values, and length of hospital stay after the procedure.

Discussion: The primary goal of the study is to determine perioperative blood loss as a measure of the efficacy of TXA, EACA, and placebo. Based on current literature and the mechanism by which the medications act, we hypothesize that TXA will be more effective at reducing blood loss than EACA or placebo and result in improved patient outcomes.

Trial registration: ClinicalTrials.gov ID: NCT00958581.

PubMed Disclaimer

References

    1. Guay J, Haig M, Lortie L, Guertin MC, Poitras B. Predicting blood loss in surgery for idiopathic scoliosis. Can J Anaesth. 1994;41(9):775–81. doi: 10.1007/BF03011583. - DOI - PubMed
    1. Hu SS. Blood loss in adult spinal surgery. Eur Spine J. 2004;13(Suppl 1):S3–5. doi: 10.1007/s00586-004-0753-x. - DOI - PMC - PubMed
    1. Nuttall GA, Horlocker TT, Santrach PJ, Oliver WC, Dekutoski MB, Bryant S. Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine. 2000;25(5):596–601. doi: 10.1097/00007632-200003010-00010. - DOI - PubMed
    1. Hur SR, Huizenga BA, Major M. Acute normovolemic hemodilution combined with hypotensive anesthesia and other techniques to avoid homologous transfusion in spinal fusion surgery. Spine. 1992;17(8):867–73. doi: 10.1097/00007632-199208000-00002. - DOI - PubMed
    1. Karkouti K, Dattilo KM. Perioperative hemostasis and thrombosis. Can J Anaesth. 2006;53(12):1260–2. doi: 10.1007/BF03021588. - DOI - PubMed

Publication types

Associated data